Core Insights - The article provides an overview of the latest performance of various mutual funds, highlighting the top and bottom performers based on net asset value changes [1]. Fund Performance Summary Top Performing Funds - The top 10 funds with the highest net value growth include: 1. Guotou Ruijin Silver Futures (LOF) A: 2.3777, up 6.27% 2. Xinao Medical Health Mixed A: 1.3136, up 4.78% 3. Xinao Medical Health Mixed C: 1.3101, up 4.77% 4. GF Innovation Medical Two-Year Holding Mixed C: 0.9070, up 4.61% 5. GF Innovation Medical Two-Year Holding Mixed A: 0.9245, up 4.61% 6. Wanjia Global Growth One-Year Holding Mixed (QDII) C: 0.9410, up 4.34% 7. Wanjia Global Growth One-Year Holding Mixed (QDII) A: 0.9656, up 4.33% 8. Xinao Enjoy Life Mixed C: 1.2091, up 4.29% 9. Xinao Enjoy Life Mixed A: 1.2301, up 4.28% 10. GF Hong Kong-Shanghai Medical Mixed A: 1.1561, up 4.26% [2][3]. Bottom Performing Funds - The bottom 10 funds with the largest declines in net value include: 1. Dongfang Alpha Zhaoyang Mixed A: 0.5213, down 6.36% 2. Dongfang Alpha Zhaoyang Mixed E: 0.5144, down 6.35% 3. Great Wall Prosperity Growth Mixed C: 1.6053, down 6.22% 4. Great Wall Prosperity Growth Mixed A: 1.6280, down 6.22% 5. Xinyuan Industry Opportunity Mixed A: 1.1447, down 6.06% 6. Xinyuan Industry Opportunity Mixed C: 1.1432, down 6.06% 7. Huaan Big Security Theme Mixed C: 3.0600, down 5.99% 8. Huaan Big Security Theme Mixed A: 3.1370, down 5.97% 9. Zhongou High-end Equipment Stock Initiation C: 1.1549, down 5.79% 10. Zhongou High-end Equipment Stock Initiation A: 1.1731, down 5.79% [3]. Market Overview - The Shanghai Composite Index opened high but experienced wide fluctuations, closing with a small decline. The total trading volume reached 3.69 trillion, with a ratio of advancing to declining stocks at 1622:3729 [5]. - The leading sectors included insurance, which rose over 2%, while the lagging sectors were aviation, semiconductors, and telecommunications, which fell over 3% [5].

公开信息显示，现任基金经理吴兴武先生:中国籍,理学硕士,持有中国证券投资基金业从业证书,曾任摩 根士丹利华鑫基金管理有限公司研究员,广发基金管理有限公司研究发展部、权益投资一部研究员、广 发多元新兴股票型证券投资基金基金经理(自2017年4月25日至2019年4月16日)、广发核心精选混合型证 券投资基金基金经理(自2015年2月17日至2020年2月10日)、广发鑫瑞混合型证券投资基金(LOF)基金经 理(自2019年4月16日至2020年7月29日)、广发再融资主题灵活配置混合型证券投资基金(LOF)基金经理 (自2019年4月16日至2020年7月31日)。现任广发轮动配置混合型证券投资基金基金经理(自2015年2月12 日起任职)、广发医疗保健股票型证券投资基金基金经理(自2018年10月16日起任职)、广发医药健康混合 型证券投资基金基金经理(自2020年10月21日起任职)、广发创新医疗两年持有期混合型证券投资基金基 金经理(自2021年3月19日起任职)。2022年11月4日起任广发竞争优势灵活配置混合型证券投资基金基金 经理。曾任广发主题领先灵活配置混合型证券投资基金基金经理。 截止2024年 ...